Search for: "United States v. Andrews" Results 121 - 140 of 2,664
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Jun 2023, 1:07 am by INFORRM
  United States On 13 June 2023, the Texas Governor signed HB4 to make Texas the tenth state to have a comprehensive privacy law. [read post]
25 Jun 2023, 10:54 am by Eugene Volokh
It's based on amicus briefs that Michael Dorf (Cornell), Andrew Koppelman (Northwestern), and I filed in past cases (and that I blogged about before), but it elaborates somewhat further on that argument. [read post]
23 Jun 2023, 1:22 pm by Gia Kokotakis
Tyler McBrien shared a motion submitted by Special Counsel Jack Smith for a protective order to limit the disclosure of discovery information in the case of United States of America v. [read post]
22 Jun 2023, 4:01 am by jonathanturley
Professor Andrew Bond denounced the United States as a “sh*t nation” and then invited conservatives to quote him. [read post]
19 Jun 2023, 2:00 am by INFORRM
On 15 June 2023, the Court of Appeal (Singh, Andrews and Warby LJJ) heard the claimant’s appeal in the case of Wright v McCormack. [read post]
18 Jun 2023, 9:00 pm by Michael C. Dorf
DorfMy latest Verdict column examines the all-but-endorsement of the unitary executive theory by Justices Thomas, Kavanaugh, and Barrett in Friday's SCOTUS decision in United States ex rel Polansky v. [read post]
6 Jun 2023, 8:00 am by ernst
Vizcaya Partners Limited v Picard: Implications for the Recognition and Enforcement of Foreign Judgments at Common Law and BeyondAnthony Kennedy and Andrew Moran [read post]
5 Jun 2023, 8:00 am by Robert Brammer
United States, 379 U.S. 241 (1964), but this time the U.S. [read post]
19 May 2023, 2:03 pm by John A. Emmons, Avery Schmitz
They concluded that as president, Trump was not an “officer of the United States” and therefore  cannot have his case removed to federal court. [read post]
15 May 2023, 9:12 am by The Regulatory Review Staff
October 13, 2022 | Negotiating Prices with Drug Manufacturers | The Inflation Reduction Act aims to constrain rapidly increasing drug prices in the United States. [read post]